Stock NVTA.Q INVITAE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Invitae Corporation

Equities

NVTA.Q

US46185L1035

Biotechnology & Medical Research

End-of-day quote OTC Markets
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
0.001 USD +100.00% Intraday chart for Invitae Corporation -67.74% -99.84%
04-25 Labcorp beats quarterly estimates on strong testing demand RE
04-25 Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln RE

Business Summary

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The Company also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The Company has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.

Number of employees: 1,700

Sales per Business

USD in Million2021Weight2022Weight Delta
Oncology
59.7 %
- - 308 59.7 % -
Women's Health
18.6 %
- - 96 18.6 % -
Rare Diseases
12.8 %
- - 66 12.8 % -
Data/Services
8.9 %
- - 46 8.9 % -

Sales per region

USD in Million2021Weight2022Weight Delta
United States
88.5 %
404 87.7 % 457 88.5 % +13.13%
Rest of World
6.9 %
49 10.6 % 36 6.9 % -26.70%
United Kingdom
1.8 %
-- 9 1.8 % -
Canada
1.7 %
8 1.6 % 9 1.7 % +16.23%
Germany
1.1 %
-- 5 1.1 % -

Managers

Managers TitleAgeSince
Randal Scott FOU
 Founder 66 12/01/10
Kenneth Knight CEO
 Chief Executive Officer 63 28/06/20
Ana Schrank DFI
 Director of Finance/CFO - 01/10/23
David Sholehvar COO
 Chief Operating Officer 56 11-12
Thomas R Brida CMP
 Compliance Officer 53 31/12/15
Christine Gorjanc BRD
 Director/Board Member 67 03/11/15
Hoki Luk IRC
 Investor Relations Contact - -
Robert Guigley PRN
 Corporate Officer/Principal - 04/09/23
Anne Deucher PRN
 Corporate Officer/Principal - -
Desarie French HRO
 Human Resources Officer - 31/12/19

Members of the board

Members of the board TitleAgeSince
Christine Gorjanc BRD
 Director/Board Member 67 03/11/15
Randal Scott FOU
 Founder 66 12/01/10
Eric Aguiar BRD
 Director/Board Member 62 31/08/10
William Osborne BRD
 Director/Board Member 64 25/01/23
Kimber Lockhart BRD
 Director/Board Member 37 09/09/20
Geoffrey Schuyler Crouse BRD
 Director/Board Member 53 29/02/12
Chitra Nayak BRD
 Director/Board Member 60 09/09/18
Jill Frizzley BRD
 Director/Board Member 49 12-06
Kenneth Knight CEO
 Chief Executive Officer 63 28/06/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 286,492,840 281,307,333 ( 98.19 %) 0 98.19 %

Shareholders

NameEquities%Valuation
ARK Investment Management LLC
11.36 %
32,550,683 11.36 % 358 058 $
BlackRock Advisors LLC
6.479 %
18,561,102 6.479 % 204 172 $
Nikko Asset Management Americas, Inc.
5.852 %
16,764,480 5.852 % 184 409 $
Nikko Asset Management Americas, Inc.
5.852 %
16,764,480 5.852 % 184 409 $
Vanguard Fiduciary Trust Co.
5.117 %
14,660,153 5.117 % 161 262 $
The Vanguard Group, Inc.
5.117 %
14,660,153 5.117 % 161 262 $
STATE STREET CORPORATION
2.156 %
6,177,962 2.156 % 67 958 $
Geode Capital Management LLC
1.946 %
5,574,850 1.946 % 61 323 $
D.E. Shaw & Co., Inc.
1.072 %
3,070,708 1.072 % 33 778 $
Renaissance Technologies LLC
0.7671 %
2,197,698 0.7671 % 24 175 $

Company contact information

Invitae Corp.

1400 16th Street

94103-5110, San Francisco

+415 374 7782

http://www.invitae.com
address Invitae Corporation(NVTA.Q)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
INVITAE CORPORATION Stock Invitae Corporation
-99.84% 286K
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-19.78% 10.91B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+44.90% 3.3B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-33.46% 2.19B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-14.31% 2.16B
VERACYTE, INC. Stock Veracyte, Inc.
-28.86% 1.5B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+25.34% 1.09B
SEEGENE, INC. Stock Seegene, Inc.
-3.28% 737M
CAREDX, INC Stock CareDx, Inc
-35.33% 404M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.53% 386M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. NVTA.Q Stock
  4. Company Invitae Corporation